marketscreener.com
GeNeuro, Inc., an NRx Company is awarded European Patent Rights for GNK-301, a novel drug candidate to treat Amyotrophic Lateral Sclerosis
MIAMI - GeNeuro, Inc., , a subsidiary of NRx Pharmaceuticals, Inc. , announced the award of a European Patent entitled 'Anti HERV K Envelope Antibody and Uses Thereof.'
The patent, together with two....